Get started
Author

Helena Paszeková

Observed name: Helena Paszekova
ORCID: 0000-0002-6479-6592
Observed ORCID: 0000-0002-6479-6592
OpenAlex ID: A5030712355
Loss of ISWI ATPase SMARCA5 (SNF2H) in Acute Myeloid Leukemia Cells Inhibits Proliferation and Chromatid Cohesion
2020 · Tomas Zikmund, Helena Paszekova, et al. · International Journal of Molecular Sciences · 22
PDF
ISWI ATPase Smarca5 Regulates Differentiation of Thymocytes Undergoing β-Selection
2019 · Tomas Zikmund, Juraj Kokavec, et al. · The Journal of Immunology · 16
Extramedullary relapse of multiple myeloma defined as the highest risk group based on deregulated gene expression data
2015 · Sabina Sevcikova, Helena Paszekova, et al. · Biomedical Papers · 15
PDF
High-Risk Multiple Myeloma: Different Definitions, Different Outcomes?
2013 · Helena Paszekova, Fedor Kryukov, et al. · Clinical Lymphoma Myeloma & Leukemia · 11
PDF
Combined Approach to Leukemic Differentiation Using Transcription Factor PU.1-Enhancing Agents
2022 · Petra Bašová, Helena Paszeková, et al. · International Journal of Molecular Sciences · 7
PDF
Developing molecular surveillance of SARS-CoV-2 in the Czech Republic (2021–2022)
2025 · Timotej Šúri, Lucie Pfeiferová, et al. · Scientific Reports · 3
PDF
Site-saturation functional screens identify PALB2 missense variants associated with increased breast cancer risk
2026 · Rick A.C.M. Boonen, Sabine C. Knaup, et al. · Nature Communications · 1
PDF
Front Matter: Volume 5 (Proceedings of CBU)
2017 · Petr Hájek, Ondřej Vít, et al. · CBU International Conference Proceedings · 1
PDF
Profil genové exprese u pacientů s mnohočetným myelomem s vysokým rizikem relapsu
2013 · Helena Paszeková
Works count: 9
Citation count: 76
H-index: 5
I10-index: 4
Year
Topic
Type